Improving Hormonal Contraceptive Supply

Health
Written By Cate Urban

The Potential Contribution of Manufacturers of Generic and Biosimilar Drugs

Research and development (R&D) companies dominate both the public- and private-sector markets in developing countries, despite the growing number of manufacturers able to produce low-cost generic and biosimilar products around the world.

This paper describes the different types of hormonal-contraceptive manufacturers and opportunities for increased competition from generic and biosimilar suppliers in the procurement field, as well as the commercial sector. Barriers addressed in the paper include the difficulty of monitoring product quality and safety in developing countries, the limited sales and marketing capability of local manufacturers, unfavorable procurement policies, and market distortions caused by well-meaning donor-funded programs.

Download PDF
Improving Hormonal Contraceptive Supply

Source: USAID
Year: 2006

Cate Urban

I founded Urban Web Renovations after 11 years of leading global marketing strategies for nonprofit organizations in Washington, DC. In each position I held, one thing remained the same – my passion for managing web sites and social media accounts for both organizations and major thought leaders.

Previous

Assessment of India’s Locally Manufactured Contraceptive Product Supply
Next

Grandmothers: A Learning Institution (available in English & French)